Edition:
United States

People: 3D Systems Corp (DDD.N)

DDD.N on New York Stock Exchange

22.40USD
22 May 2017
Change (% chg)

-- (--)
Prev Close
$22.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
637,110
52-wk High
$23.70
52-wk Low
$11.59

Curran, William 

Mr. William Edward Curran is anIndependent Director of 3D Systems Corporation. Currently retired, Mr. Curran has served as a director of Profound Medical, a public company developing a treatment for prostate cancer using ablative ultrasound and guided by magnetic resonance imaging and thermometry, since 2012. Previously, Mr. Curran served as non-executive Chairman and Director of Resonant Medical, an early-stage privately owned company specializing in three-dimensional ultrasound image-guided adaptive radio therapy products, until May 2010 at which time Resonant was sold to Elekta A.B. He also served until May 2009 as a director of Ventracor, a global medical device company which produced an implantable blood pump, at which time the directors brought in an administrator under Australian law. For more than five years prior to 2004, he held diverse functional and senior management positions with Philips Electronics and Philips Medical Systems. His experience at Philips Medical Systems, a medical device manufacturer, included positions as Chief Operating Officer and Chief Financial Officer, and while at Philips Electronics North America he served as President and Chief Executive Officer as well as Chief Financial Officer.

Basic Compensation

Total Annual Compensation, USD 130,250
Restricted Stock Awards, USD 99,991
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 230,241

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

G. Walter Loewenbaum

399,991

Vyomesh Joshi

8,183,980

John McMullen

3,511,080

Kevin McAlea

2,921,500

Charles Hull

2,885,030

Andrew Johnson

2,919,570
As Of  30 Dec 2016